Eye disorder

1 paper1 finding

Humans1

Associations

1

Semaglutide

upin humans1

1 study

Semaglutide is associated with eye disorder in humans (ROR 2.67, 95% CI 1.54-4.63).
“Eye disorders were more frequently reported with semaglutide than liraglutide (ROR 2.67; 95% CI 1.54-4.63)”
Humanscompared with liraglutide
Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs)
Naunyn-Schmiedeberg's archives of pharmacology22 Aug 2026

More on Semaglutide

Latest

1 in 12 months

Naunyn-Schmiedeberg's Archives of Pharmacology22 Aug

Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs)

Cohort study in peopleGLP-1 receptor agonists

Inflammopharmacology24 Sep

Resveratrol: potential therapeutic effects on ocular health

ReviewInterventions

Inflammopharmacology19 Aug

Regulation of toll-like receptor signaling pathways in age-related eye disease: from mechanisms to targeted therapeutics

ReviewMechanisms

Lancet15 Oct

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

Non-randomised trial in 18 peopleAge-related macular degeneration